100ug-Anti- Tissue Factor Pathway Inhibitor (TFPI)

Size

100ug

Catalog no#

MAA394Hu23-100ug

Price

353 EUR

Image number

1

Aplication

WB

Species reactivity

Human

Tissue

tissue

Concentration

1mg/ml

Sequence of immunogen

Asp29~Cys251

Clonality

Mouse monoclonal

Delivery condition

4℃ with ice bags

Organism Species

Homo sapiens (Human)

Item Name

Tissue Factor Pathway Inhibitor

Source

Monoclonal antibody preparation

Purification

Protein A + Protein G affinity chromatography

Buffer Formulation

PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.

Immunogen

RPA394Hu03-Recombinant Tissue Factor Pathway Inhibitor (TFPI)

Applicable Secondary Antibody

SAA544Mu08, SAA544Mu09, SAA544Mu07, SAA544Mu19, SAA544Mu18, SAA544Mu17

Alternative Names

TFI; EPI; LACI; TFPI1; Lipoprotein-Associated Coagulation Inhibitor; Extrinsic pathway inhibitor

Storage instructions

Avoid repeated freeze/thaw cycles. Store at 4 ℃ for frequent use. Aliquot and store at -20℃ for 12 months.

Description

This antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided.Antibody for research use.Aplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells.Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.6